首页> 美国卫生研究院文献>Journal of Diabetes Science and Technology >COVID-19 Pandemic Triggers Telemedicine Regulation and Intensifies Diabetes Management Technology Adoption in Brazil
【2h】

COVID-19 Pandemic Triggers Telemedicine Regulation and Intensifies Diabetes Management Technology Adoption in Brazil

机译:Covid-19 Pandemic触发远程医疗监管和加剧糖尿病管理技术在巴西采用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We have learned that a pandemic can change overnight our routines, behaviors, society, and world economies with unexpected and unpredictable effects. We still have a lot to learn about this infection and its effects on healthcare systems. However, we already know that people with diabetes mellitus are at a particularly higher risk to be infected and certainly are more prone to present a further severe form of the COVID-19, especially if their glycemia levels are not controlled. Since there is no specific treatment or vaccine for this disease, social distancing is currently the single most effective available measure. Therefore, during these critical days, medical management of patients with diabetes has been struggling with regular in-person appointments, which creates opportunities for the use of technology tools that effectively enables patient-physician relationship.
机译:我们了解到,流行病可以随着我们的常规,行为,社会和世界经济而变化,具有意外和不可预测的影响。我们仍然有很多了解这种感染及其对医疗系统的影响。然而,我们已经知道糖尿病患有糖尿病的人患有特别较高的风险,肯定更容易出现进一步严重的Covid-19,特别是如果它们的血肿水平没有控制。由于这种疾病没有特异性治疗或疫苗,因此社会偏差是目前最有效的可用措施。因此,在这些临时日期间,糖尿病患者的医学管理一直在努力与普通的亲人约会,这为使用技术工具提供了有效实现患者医师关系的机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号